S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The Next Nvidia? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
[Urgent!] Generational Wealth Gameplan (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The Next Nvidia? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
[Urgent!] Generational Wealth Gameplan (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The Next Nvidia? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
[Urgent!] Generational Wealth Gameplan (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The Next Nvidia? (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Did You Get Your Free Bitcoin Yet? (Ad)
3 Steel Stocks Could Soar on New China Tariffs
These are the Top 4 Stocks for Buybacks in 2024
[Urgent!] Generational Wealth Gameplan (Ad)
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
NASDAQ:SESN

Sesen Bio (SESN) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free SESN Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$0.63
▼
$12.99
52-Week Range
N/A
Volume
93,330 shs
Average Volume
1.07 million shs
Market Capitalization
$2.56 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
SESN stock logo

About Sesen Bio Stock (NASDAQ:SESN)

Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.

SESN Stock News Headlines

April 10, 2024 | startribune.com
Trey Mewes
August 4, 2023 | fool.com
Sesen Bio (NASDAQ: SESN)
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
March 6, 2023 | bizjournals.com
After revisions, Philadelphia-based Carisma Therapeutics poised to close merger with Sesen Bio
March 2, 2023 | msn.com
Sesen Bio wins shareholder approval for Carisma merger
March 2, 2023 | finance.yahoo.com
Sesen Bio Stockholders Approve Merger with Carisma Therapeutics
February 28, 2023 | finance.yahoo.com
Sesen Bio Reports Fourth Quarter and Full-Year 2022 Financial Results
February 24, 2023 | benzinga.com
SHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and SHBI Shareholders About Its Ongoing Investigations
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
February 21, 2023 | finance.yahoo.com
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Sesen Bio Stockholders Vote "FOR" All Proposals to Approve Pending Merger With Carisma
February 17, 2023 | stockhouse.com
BML, One of Sesen Bio's Top Stockholders, Announces Support for Pending Merger with Carisma Therapeutics
February 16, 2023 | businesswire.com
Leading Independent Proxy Advisory Firm ISS Recommends Sesen Bio Stockholders Vote “FOR” All Proposals at March 2 Special Meeting
February 16, 2023 | finance.yahoo.com
Sesen Bio to Host Webcast with Carisma Therapeutics to Discuss Pending Merger
February 15, 2023 | finance.yahoo.com
5 big dividend moves: Group 1 Automotive hikes by 20% | Pro Recap
February 15, 2023 | finance.yahoo.com
BML, One of Sesen Bio’s Top Stockholders, Announces Support for Pending Merger with Carisma Therapeutics
February 14, 2023 | bizjournals.com
Sesen Bio, Carisma Therapeutics amend merger deal after reaching agreement with investor group
February 14, 2023 | msn.com
Sesen gains 11% on amended terms for merger with Carisma
February 14, 2023 | finance.yahoo.com
Sesen Bio and Carisma Therapeutics Announce Increased Special Cash Dividend and Stockholder Support for Pending Merger
February 6, 2023 | finance.yahoo.com
Sesen Bio (NASDAQ:SESN) investors are sitting on a loss of 37% if they invested three years ago
February 2, 2023 | finance.yahoo.com
Sesen Bio Files Investor Presentation in Connection with Pending Carisma Therapeutics Merger
February 2, 2023 | finance.yahoo.com
The Petri Dish: Departed White House adviser returns to the Broad
January 30, 2023 | finance.yahoo.com
Sesen Bio Receives NASDAQ Delisting Notice
January 26, 2023 | finance.yahoo.com
Sesen Bio Reiterates Confidence that Pending Merger with Carisma is in Best Interests of Stockholders
January 19, 2023 | finance.yahoo.com
Sesen Bio Files Definitive Proxy Statement and Mails Letter to Stockholders in Connection with Pending Merger with Carisma Therapeutics
January 6, 2023 | benzinga.com
SHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and APEN Shareholders About Its Ongoing Investigations
January 5, 2023 | finance.yahoo.com
Investor Group Issues Letter to Sesen Bio’s Board of Directors Regarding Intent to Vote AGAINST Proposed Carisma Merger
January 4, 2023 | finance.yahoo.com
Sesen Bio Reiterates Confidence in Pending Merger with Carisma Therapeutics
See More Headlines
Receive SESN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sesen Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2021
Today
4/18/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SESN
CUSIP
N/A
CIK
1485003
Web
www.sesenbio.com
Phone
(617) 444-8550
Fax
617-858-0911
Employees
35
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-19,880,000.00
Net Margins
N/A
Pretax Margin
-59.40%
Return on Equity
6.70%
Return on Assets
5.41%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.10
Quick Ratio
6.10

Sales & Book Value

Annual Sales
$40 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
3.39
Book Value
$0.78 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
203,490,000
Free Float
196,980,000
Market Cap
$2.56 billion
Optionable
Optionable
Beta
0.83
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

SESN Stock Analysis - Frequently Asked Questions

How were Sesen Bio's earnings last quarter?

Sesen Bio, Inc. (NASDAQ:SESN) released its earnings results on Sunday, November, 7th. The company reported $7.20 earnings per share for the quarter, topping the consensus estimate of ($1.40) by $8.60.

When did Sesen Bio's stock split?

Sesen Bio's stock reverse split before market open on Wednesday, March 8th 2023. The 1-20 reverse split was announced on Wednesday, March 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, March 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Sesen Bio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sesen Bio investors own include Amarin (AMRN), XOMA (XOMA), VBI Vaccines (VBIV), Advanced Micro Devices (AMD), Verastem (VSTM), Sorrento Therapeutics (SRNE), Novavax (NVAX), Biocept (BIOC), Micron Technology (MU) and OPKO Health (OPK).

This page (NASDAQ:SESN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The Next Nvidia?
InvestorPlace
How Biden has already won 2024
Porter & Company
Options trading has suddenly become more reliable.
Eagle Publishing
1970’s computer coder issues shocking A.I. warning
TradeSmith